Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

Pharmacology

Volumn 61, Issue 3, 2000, Pages 167-173

  Liggett, Stephen B ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ML 0564 ^*  (United States)

Author keywords

Adenylyl cyclase; Asthma; Beta agonist; Desensitization; G protein; Heart failure; Polymorphism; Tachyphylaxis

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; ISOPROTEIN; NORADRENALIN;

ASTHMA; DRUG TARGETING; EXON; GENETIC TRANSFECTION; HAPLOTYPE; HEART FAILURE; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; REVIEW; TRANSGENIC MOUSE;

EID: 0033832449     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028397     Document Type: Review

References (31)

1. 2-adrenergic receptor in normal and asthmatic subjects. Am J Resp Cell Mol Biol 1993;8:334-339.
2. 1-adrenergic receptor polymorphisms: Analysis of c145A>G and c1165G>C. Hum Mutat 1999;14:271.
3. 2-adrenergic receptor in nocturnal and non-nocturnal asthma: Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995;95: 1635-1641.
4. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995;345:1213-1214.
5. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-1539.
6. 1-adrenergic receptor. J Biol Chem 1999;274:12670-12674.
7. 2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158:787-791.
8. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, Skrabal F, Caulfield M: Essential hypertension in African Carribeans associates with a variant of the beta2-adrenoceptor. Hypertension 1997;30:773-776.
9. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P: Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered beta-2 adrenoceptor function. J Clin Invest 1997;100:3005-3013.
10. Small KM, Rathz DA, Liggett SB: Identification of adrenergic receptor polymorphisms. Methods Enzymol 2000; in press.
11. 2-adrenergic receptor polymorphisms: Relevance to receptor function and asthmatic phenotypes; in Liggett SB, Meyers DA (eds): The Genetics of Asthma, New York, Marcel Dekker, 1996, pp 455-478.
12. 2-adrenergic receptor regulate receptor expression. J Clin Invest 1998;102: 1927-1932.
13. Scott MGH, Swan C, Wheatley AP, Hall IP: Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene. Br J Pharmacol 1999;126: 841-844.
14. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; in press.
15. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268:23116-23121.
16. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9419.
17. 2-adrenergic receptor plymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996;93:10483-10488.
18. Rosenthal N, Schwartz RS: In search of perverse polymorphisms. N Engl J Med 1998;338: 122-124.
19. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Resp Cell Mol Biol 1995;13:25-33.
20. 2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000;139:537-542.
21. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P: Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998;53:1455-1460.
22. 2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999;84:1754-1757.
23. 2 adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma. Thorax 1995;50:353-359.
24. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R: Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
25. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999;65:519-525.
26. 2-agonist therapy in asthma. Eur Respir J 1998;11:589-593.
27. 2-agonist therapy. Clin Sci 2000;96:253-259.
28. 2-adrenoceptors in asthmatic patients. Chest 2000;328:324-328.
29. Tan S, Hall IP, Dewar J, Dow E, Lipworth B: Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997;350:995-999.
30. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; in press.
31. Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, Lazarus SC, Lemaske RF, Martin RJ, Peters SP, et al: Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 2000;335: 841-847.